Principales publications
"L'apport du carvedilol dans le traitement de l'insuffisance cardiaque : une application au
cas de la France", P. Lévy, J. Dubois-Randé, P. Cohen-Solal et E. Lévy, Archives des
maladies du cœur et des vaisseaux, 2001; 94(2) : 166-70.
"A general model of the effects of sleep medications on the risk and cost of motor vehicle
accidents and its application to France", J. Menzin, K. Lang, P. Lévy, E. Lévy,
PharmacoEconomics, 2001, 19(1): 69-78.
"Bisoprolol dans l'insuffisance cardiaque : efficacité et coûts dans le cadre français selon
CIBIS II", P. Lévy, JL. Mérot, Ph. Lechat, E. Lévy et O. Bogillot, Thérapie, 2001, 56: 421-25.
"Pharmacoeconomic considerations in assessing and selecting congestive heart failure
therapies", E. Lévy, P. Lévy, PharmacoEconomics, 2002; 20(14): 963-977.
"The cost of osteoporosis in men : the French situation", P. Lévy, E. Lévy, and the Medical
Expert Group, Bone, 2002, 30(4) : 631-636.
"Economic evaluation of antiepileptic drug therapy : a methodologic review", P. Lévy,
Epilepsia, 2002, 43(5) : 550-558.
"Cross-Country measures for monitoring epilepsy care by ILAE Commission on healthcare
policy ", C. Begley, G. Baker, E. Begui, J. Butler, D. Chisholm, J. Langfitt, P. Lévy, C.
Pachlatko, S. Wiebe, K. Donaldson, Epilepsia, 2007, 48(5) : 990-1001.
"The comparative effects of bariatric surgery on weight and type 2 diabetes", P. Lévy, M.
Fried, F. Santini, N. Finer, Obesity Surgery, 2007, 17(9) : 1248-1256.
”Impact of the introduction of new vaccines and vaccine wastage rate on the cost-
effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health
district”, C. Ebontane Ebong, P. Lévy, Cost Effectiveness and Resource Allocation; 2011,
9:9
”Cost-effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana”,
A.K. Abotsi, E. Inkoom, E. Ribaira, R. Le Mentec, P. Lévy, H. Lafarge, and A. de Sousa,
International Journal of Tropical Disease and Health, 2012, 2(1):1-15
“Cost of poor adherence to anti-hypertensive therapy in five European countries”, Mennini F. S.,
Marcellusi A., von der Schulenburg J. M. Graf, Gray A., Levy P., Sciattella P., Soro M., Staffiero
G., Zeidler J., Maggioni A., Schmieder R. E., The European Journal of Health Economics, 2015.
16(1): p. 65-72
“Cost
‑
effectiveness analysis of routine immunization and supplementary immunization activity
for measles in a health district of Benin”, Kaucley L., Levy P, Cost Effectiveness and Resource
Allocation, 2015, 13:14; doi:10.1186/s12962-015-0039-7